How can biotech companies use patient-reported outcomes to bring better drugs forward for patients? Generally, patient-reported outcomes (PROs) provide complementary information to measured or ...
Please provide your email address to receive an email when new articles are posted on . In business, the focus on consistent outcomes includes managing “inputs,” such as uniform materials and ...
Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies Using the Enhancing Quality and Transparency of Health Research (EQUATOR) Network's methodological ...
Management of cancer patients' symptoms always has been a challenge for providers, especially among racial/ethnic minoritized (REM) populations that often face health disparities that might negatively ...
WEST PALM BEACH, Fla. — Patient-reported outcomes (PROs) define the issues that matter to the patient, but their potential in multiple sclerosis (MS) is likely to remain unfulfilled until barriers, ...
There is a lack of systematic solutions to manage supportive care issues in racial/ethnic minorities (REM) receiving treatment for cancer. We developed and implemented an electronic patient-reported ...
As part of our commitment, we've once again partnered with Statista, Inc. to evaluate the implementation of Patient Reported Outcome Measures (PROMs) in the leading hospitals around the world.
Please provide your email address to receive an email when new articles are posted on . A viewpoint paper outlined the benefits of a well-coordinated patient-reported outcomes collection system. The ...
Clinician and patient responses for cutaneous cGVHD were associated with higher nonrelapse mortality when comparing worsening vs improved disease.
When outcome selection and prioritisation are defined early in development, the evidence base supports continuity from trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results